Guidelines for management of atopic dermatitis

Journal of Dermatology

Volumn 36, Issue 10, 2009, Pages 563-577

  Saeki, Hidehisa ^a   Furue, Masutaka ^b   Furukawa, Fukumi ^c   Hide, Michihiro ^d   Ohtsuki, Mamitaro ^e   Katayama, Ichiro ^f   Sasaki, Rikako ^g   Suto, Hajime ^h   Takehara, Kazuhiko ⁱ  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Rikako's Clinic of Dermatology   (Japan)

^h JUNTENDO UNIVERSITY   (Japan)

ⁱ KANAZAWA UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Cyclosporine; Guidelines; Systemic antihistamines; Tacrolimus ointment; Topical corticosteroids

Indexed keywords

ALCLOMETASONE DIPROPIONATE; AMCINONIDE; ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CETIRIZINE; CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; DEXAMETHASONE 17 VALERATE; DIFLORASONE DIACETATE; DIFLUCORTOLONE VALERATE; DIFLUPREDNATE; EBASTINE; EMOLLIENT AGENT; EPINASTINE; FEXOFENADINE; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; HALCINONIDE; HYDROCORTISONE BUTYRATE; MOMETASONE FUROATE; PREDNISOLONE; PREDNIVAL ACETATE; TACROLIMUS; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG;

ACNE; ATOPIC DERMATITIS; ATOPY; BACTERIAL SKIN DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECZEMA; ERYTHEMA; FLUSHING; HUMAN; HYPERTRICHOSIS; LICHENOID ERUPTION; MYCOSIS; PAPULE; PATHOGENESIS; PATIENT COUNSELING; PHOTOTHERAPY; PRACTICE GUIDELINE; PRURITUS; REVIEW; SEDATION; SIDE EFFECT; SKIN ATROPHY; SKIN INFECTION; SKIN INFLAMMATION; SKIN NODULE; VIRUS INFECTION;

ALGORITHMS; DERMATITIS, ATOPIC; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 70349617974     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2009.00706.x     Document Type: Review

References (54)

1. The Japanese Dermatologocal Association. Definition and diagnostic criteria for atopic dermatitis. Jpn J Dermatol 1994 104 : 1210 (In Japanese).
2. Yoshida H. Interim report from the Advisory Committee for Atopic Dermatitis Severity Classification. Jpn J Dermatol 1998 108 : 1491 1496 (In Japanese).
3. Aoki T. The second report from the Advisory Committee for Atopic Dermatitis Severity Classification. Jpn J Dermatol 2001 111 : 2023 2033 (In Japanese).
4. Kawashima M, Takigawa M, Nakagawa H et al. Guidelines for therapy for atopic dermatitis. Jpn J Dermatol 2000 110 : 1099 1104 (In Japanese with English abstract).
5. Furue M, Furukawa F, Hide M, Takehara K. Guidelines for therapy for atopic dermatitis 2003. Jpn J Dermatol 2003 113 : 451 457 (In Japanese with English abstract)
6. Furue M, Furukawa F, Hide M, Takehara K. Guidelines for therapy for atopic dermatitis 2004. Jpn J Dermatol 2004 114 : 135 142 (In Japanese with English abstract)
7. Furue M, Saeki H, Furukawa F et al. Guideline for management of atopic dermatitis. Jpn J Dermatol 2008 118 : 325 342 (In Japanese with English abstract).
8. Tagami H. Japanese Dermatological Association Criteria for the diagnosis of atopic dermatitis. J Dermatol 1995 22 : 966-967. (In Japanese with English abstract)
9. Hanifin JM, Rajka G. Diagnostic features of atopic eczema. Acta Dermatol Venereol (Stockh) 1980 92 : 44 47.
10. Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 2003 49 : 1088 1095.
11. Williams HC, Burney PGJ, Pembroke AC, Hay RJ. The UK Working Party's Diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 1994 131 : 406 416.
12. Saeki H, Iizuka H, Mori Y et al. Community validation of the U.K. diagnostic criteria for atopic dermatitis in Japanese elementary schoolchildren. J Dermatol Sci 2007 47 : 227 231.
13. Williams H, Robertson C, Stewart A et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 1999 103 : 125 138.
14. Nishima S, Odajima H. Prevalence of childhood allergic diseases in Japan using international study of asthma and allergies in childhood (ISAAC) phase I protocol. Jpn J Pediatr Allergy Clin Immunol 2002 16 : 207 220. (In Japanese with English abstract).
15. Hanifin JM, Thurston M, Omoto M et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol 2001 10 : 11 18.
16. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989 144 : 13 14.
17. Yamada H, Noda T, Matsukura M, Sugihara K, Yudate T, Tezuka T. Evaluation of itching by visual analogue scale (VAS). Skin Res 1996 38 (Suppl 18) 71-77. In Japanese with English abstract).
18. Kawashima M, Harada S, Tango T. Evaluation of itch based on a new rating scale using patient diary. Jpn J Clin Dermatol 2002 56 : 692 697 In Japanese
19. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994 19 : 210 216.
20. Holm EA, Wulf HC, Stegmann H, Jemec GB. Life quality assessment among patients with atopic eczema. Br J Dermatol 2006 154 : 719 725.
21. Higaki Y, Kawamoto K, Kamo T, Horikawa N, Kawashima M, Chren MM. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Dermatol 2002 29 : 693 698.
22. Fukuhara S. Measuring HRQOL of patients with skin disease. Manual of the DLQI and the Skindex29 Japanese Version. Shorinsha, Tokyo 2004 In Japanese
23. Takahashi N, Suzukamo Y, Nakamura M et al. Japanese version of the Dermatology Life Quality Index: validity and reliability in patients with acne. Health Qual Life Outcomes 2006 4 : 46.
24. Tamaki K, Saeki H, Kadono T et al. Serum TARC/CCL17 levels as a disease marker of atopic dermatitis. Jpn J Dermatol 2006 116 : 27 39 In Japanese with English abstract
25. Bleehen SS, Chu AC, Hamann I, Holden C, Hunter JA, Marks R. Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment. Br J Dermatol 1995 133 : 592 597.
26. Koopmans B, Lasthein Andersen B, Mork NJ, Austad J, Suhonen RE. Multicentre randomized double-blind study of locoid lipocream fatty cream twice daily versus locoid lipocream once daily and loco-base once daily. J Dermatol Treat 1995 6 : 103 106.
27. Long CC, Finlay AY. The finger-tip unit - a new practical measure. Clin Exp Dermatol 1991 16 : 444 447.
28. Long CC, Finlay AY, Averill RW. The rule of hand: 4 hand areas = 2 FTU = 1 g. Arch Dermatol 1992 128 : 1129 1130.
29. Shimao S. Problems regarding side effects of corticosteroid therapy in the field of dermatology. Nishinihon J Dermatol 1978 40 : 5 24 In Japanese with English abstract
30. Takeda K, Harada T, Asato T, Ishimoto A, Nomoto M. Kuramoto M.Review on systemic effects of topical corticosteroids - with special reference to adrenocortical suppression following percutaneous absorption. Igaku No Ayumi 1977 101 : 817 829 In Japanese
31. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J Am Acad Dermatol 2005 53 : S186 S194.
32. Reitamo S, Rustin M, Harper J et al. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients. Br J Dermatol 2008 159 : 942 951.
33. Arellano FM, Wentworth CE, Arena A, Fernandez C, Paul CF. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol 2007 127 : 808 816.
34. Margolis DJ, Hoffstad O, Bilker W. Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults. Dermatology 2007 214 : 289 295.
35. Ellis C, Luger T, Abeck D et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 2003 148 (Suppl 63 3 10.
36. Wollenberg A, Reitamo S, Girolomoni G et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008 63 : 742 750.
37. Breneman D, Fleischer AB Jr., Abramovits W et al. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus versus vehicle. J Am Acad Dermatol 2008 58 : 990 999.
38. Kawashima M, Hayashi N, Nogita T, Yanagisawa K, Mizuno A. The usefulness of moisturizers for maintenance of remission in atopic dermatitis. Jpn J Dermatol 2007 117 : 1139 1145 In Japanese with English abstract
39. Harada S. A study of the effect on itch and quality of life of atopic dermatitis patients treated by standard therapy with anti-allergic drug. Jpn J Clin Dermatol 2006 60 : 661 667 In Japanese
40. Tashiro M, Okamura N et al. Non-sedating second-generation antihistamines: the penetration through blood-brain barrier by PET. Nishinihon J Dermatol 2009 71 : 3 6 In Japanese
41. Furue M, Ikezawa Z et al. Guidelines for the diagnosis and treatment of urticaria and angioedema. Jpn J Dermatol 2000 115 : 703 715 In Japanese with English abstract
42. 2LEN/EDF guideline: management of urticaria. Allergy 2006 61 : 321 331.
43. Igarashi A, Nakagawa H, Takigawa M et al. Guidance for the use of Cyclosporin MEPC for atopic dermatitis. Jpn J Clin Dermatol 2009 (in press In Japanese MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 1992 126 : 179 184.
44. Sheehan MP, Rustin MH, Atherton DJ et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet 1992 340 : 13 17.
45. Fung AYP, Look PCN, Chong L-Y, But PPH, Wong E. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol 1999 38 : 387 392.
46. Kobayashi H, Ishii M, Takeuchi S et al. Efficacy and safety of a traditional herbal medicine, hochu-ekki-to in the long-term management of kikyo (delicate constitution) patients with atopic dermatitis: a 6-month, multicenter, double-blind, randomized, placebo-controlled study. Evid Based Complement Alternat Med 2008 Jan 31 [Epub ahead of print]
47. Investigation of scratching behavior in atopic dermatitis patients. Jpn J Dermatol 2000 110 : 275 282 In Japanese with English abstract
48. Atopic dermatitis (disseminated neurodermatitis) of young adults. Arch Derm Syph 1936 34 : 935 957.
49. Nagai Y, Hayasaka S, Kadoi C. Cataract progression in patients with atopic dermatitis. J Cataract Refract Surg 1999 25 : 96 99.
50. Taniguchi H, Ohki O, Yokozeki H et al. Cataract and retinal detachment in patients with severe atopic dermatitis who were withdrawn from the use of topical corticosteroid. J Dermatol 1999 26 : 658 665.
51. Takehara K, Iizuka H, Ito M et al. Survey of health damage caused by inadequate treatment for atopic dermatitis. Jpn J Dermatol 2000 110 : 1095 1098 (In Japanese with English abstract)
52. Der-Petrossian M, Seeber A, Honigsmann H, Tanew A. Half-side comparison study on the efficacy of 8-methoxypsoralen bath PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 2000 142 : 39 43.
53. Stern RS, Lunder EJ. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). Arch Dermatol 1998 134 : 1582 1585.
54. Morita A. New ultraviolet phototherapy for atopic dermatitis. Allergol Immunol 2004 11 : 1097 1103 In Japanese T, Manabe M, Takenouchi T et al. Guidelines for management of skin cancer. Jpn J Dermatol 2007 117 : 1855 1925 In Japanese.)